BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
A
Atrogi at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Atrogi takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover cardiometabolic medicine beyond GLP-1 and the use of AI in clinical trials. The trials session looks at how AI can transform trial operations and speed up development.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
A Atrogi Stockholm, Sweden | |
Develops oral small molecules for type 2 diabetes and obesity that increase glucose uptake in skeletal muscle. | Panel Tue Nov 10 16:00–16:45 AI and Innovation in Clinical Trials: Transforming Operations and Accelerating Development How AI can speed clinical trials, from drafting trial plans and finding patients to computer-simulated patients that cut how many real ones are needed. Panel Tue Nov 10 10:00–10:45 Cardiometabolic innovations beyond GLP-1 – Where are we now? Which drug approaches beyond GLP-1 medicines are drawing attention for obesity, diabetes and heart disease risk, and where money and partnerships are going. |
Find decision makers at Atrogi
Tell us what you sell and we’ll find the people at Atrogi most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction